CDSCO UID MFG/IVD/2023/000099_d85ad15e9f044930c9d921fdb9225d2f_f7198081e8bd20178db23c30a9518edf

Dengue NS1 Ag Rapid Test Device

SR Bioera Private Limited.·Device Class Class C·India CDSCO
Registration details
UID
MFG/IVD/2023/000099_d85ad15e9f044930c9d921fdb9225d2f_f7198081e8bd20178db23c30a9518edf
Device class
Class C
Approving authority
Central Drug Standards Control Organization, Ahmedabad
Product information
Dengue NS1 Antigen Rapid Test is a lateral flow immunochromatographic test for the qualitative detection of dengue NS1 antigen in human serum/ plasma/whole blood specimen
Other products from SR Bioera Private Limited.
Products from the same license holder (10 products)
Viral Transport System
Brand: VTM kit
Class A
Leptospira IgG/IgM Rapid Test.
Brand: Urine/Serum
Class B
Vitamin D Rapid Test Device
Brand: Urine/Serum
Class B
Dengue IgM/IgG Rapid Test Device.
Brand: Urine/Serum
Class B
Luteinizing Hormone Rapid Test - Midstream
Brand: Urine/Serum
Class B
Chikungunya IgM/IgG Rapid Test Device.
Brand: Urine/Serum
Class B
Chagas Ab Test Device
Brand: Urine/Serum
Class B
Pregnancy Rapid Test Dipstick.
Brand: Urine/Serum
Class B
Luteinizing Hormone Rapid Test Device
Brand: Urine/Serum
Class B
TSH Rapid Test Device.
Brand: Urine/Serum
Class B
About this record

Dengue NS1 Ag Rapid Test Device is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000099_d85ad15e9f044930c9d921fdb9225d2f_f7198081e8bd20178db23c30a9518edf. The license holder is SR Bioera Private Limited., and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, Ahmedabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.